S-4 - Semnur Pharmaceuticals, Inc. (0001584541) (Filer)

1 min to read

S-4 – Semnur Pharmaceuticals, Inc. (0001584541) (Filer)

Filed: 2024-11-06 AccNo: 0001193125-24-251843 Size: 15 MB
Source: S-4 – Semnur Pharmaceuticals, Inc. (0001584541) (Filer)

Ribbon Acquisition Corp Announces Closing of $50 Million Initial Public Offering.

New York, New York, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ribbon Acquisition Corp (NASDAQ: RIBBU, the “Company”) today announced the...
A New Generation of SPACs Leads the Way Into 2025

After a two-and-a-half-year lull in SPAC activity, the second half of 2024 brought glimmers of sunshine to the otherwise gloomy...
ISS, Glass Lewis and BlackRock Issue 2025 Voting Guidelines

As companies begin preparing for the 2025 proxy season, Institutional Shareholder Services Inc. (ISS) and Glass Lewis, the leading providers...
Sec Lit IQ: MoFo’s Quarterly Federal Securities Litigation and Delaware Corporate Litigation Newsletter (Q4 2024)

We are pleased to announce the launch of MoFo’s new quarterly newsletter highlighting the most important developments in federal securities...
OLNS#13 – M&A in German Tech: A Playbook for Buyers and Sellers – English

About the Orrick Legal Ninja Series – OLNS In substantially all of the major world markets, we have dedicated technology...